Future studies should evaluate BAIAP2L2’s predictive accuracy in large patient cohorts and explore whether it can serve as an independent predictor or work in conjunction with existing biomarkers to refine PCa prognosis and treatment selection. Here, BAIAP2L2 is linked to posterior cortical atrophy.